# Glossary

## CH 01 

### Sequencing Technologies & Data

- **Next-generation sequencing (NGS)** — High-throughput DNA sequencing technologies that allow rapid sequencing of large stretches of DNA, producing millions of short reads in parallel.
- **Illumina sequencing** — A widely used NGS technology that utilizes reversible dye-terminators to sequence DNA by synthesis
- **Short reads / Paired-end reads** — DNA sequences generated by NGS technologies, typically ranging from 50 to 300 base pairs in length. Paired-end reads are sequenced from both ends of a DNA fragment, providing additional information for alignment.
- **Long-read sequencing (PacBio HiFi, Oxford Nanopore)** — DNA sequencing technologies that produce longer reads, typically ranging from several kilobases to megabases, allowing for better resolution of complex genomic regions.
- **Circular consensus sequencing** — A sequencing method used by PacBio to generate highly accurate long reads by repeatedly sequencing the same DNA molecule.
- **Base calling** — The process of determining the nucleotide sequence from raw sequencing data.
- **FASTQ** — A file format that stores both nucleotide sequences and their corresponding quality scores.
- **Read depth / Coverage (e.g., 30×, 100×)** — The number of times a particular nucleotide is sequenced, indicating the reliability of the sequencing data.

### Targeting Strategies

- **Targeted gene panel** — A sequencing approach that focuses on a specific set of genes or genomic regions of interest, allowing for cost-effective analysis of known disease-associated variants.
- **Whole-exome sequencing (WES)** — A sequencing approach that targets all protein-coding regions of the genome, providing a comprehensive view of coding variants.
- **Whole-genome sequencing (WGS)** — A sequencing approach that captures the entire genome, including coding and non-coding regions, providing the most comprehensive view of genetic variation.
- **Capture efficiency** — The effectiveness of a targeted sequencing approach in enriching the regions of interest, impacting the overall quality and coverage of the data.

### Alignment & Processing

- **Read alignment / Mapping** — The process of aligning sequencing reads to a reference genome to determine their genomic origin.
- **Seed-and-extend alignment** — An algorithmic approach for read alignment that first identifies short matching sequences (seeds) and then extends the alignment around these seeds.
- **PCR duplicates** — Identical sequencing reads that originate from the same DNA fragment, often resulting from PCR amplification, which can bias variant calling.
- **Base quality score recalibration (BQSR)** — A process that adjusts the quality scores of sequencing reads to correct for systematic errors made by the sequencer.
- **Mapping quality** — A measure of the confidence that a read is correctly aligned to the reference genome.
- **Reference bias** — The tendency for sequencing and alignment processes to preferentially detect alleles present in the reference genome.

### Variant Calling

- **Variant calling** — The process of identifying variants from sequencing data by comparing it to a reference genome.
- **Genotype likelihood** — The probability of observing the sequencing data given a particular genotype.
- **Pair-HMM (pair hidden Markov model)** — A statistical model used in variant calling to calculate the likelihood of different alignments between reads and the reference genome.
- **Joint genotyping / Cohort calling** — The process of simultaneously calling variants across multiple samples to improve accuracy and consistency.
- **gVCF (genomic VCF)** — A variant call format that includes information about both variant and non-variant sites, allowing for joint genotyping.
- **VCF (variant call format)** — A standardized file format for storing variant information, including SNPs, indels, and structural variants.
- **VQSR (Variant Quality Score Recalibration)** — A method for improving the accuracy of variant calls by modeling the relationship between variant quality scores and various annotation metrics.
- **Pileup** — A summary of the base calls at each position in a set of aligned sequencing reads, used for variant calling and visualization.

### Phasing

- **Haplotype phasing** — The process of determining which variants are inherited together on the same chromosome.
- **Read-backed phasing** — A method of phasing that uses sequencing reads that span multiple variants to determine their phase.
- **Statistical phasing** — A method of phasing that uses population-level genotype data and statistical models to infer haplotypes.
- **Compound heterozygosity** — The presence of two different variants at a particular gene locus, one on each chromosome of a pair.
- **Cis vs. trans configuration** — Describes the relative arrangement of two variants on the same chromosome (cis) or on different chromosomes (trans).

### Variant Types

- **SNV (single nucleotide variant)** — A variation in a single nucleotide that occurs at a specific position in the genome.
- **Indel** — An insertion or deletion of bases in the genome of an organism.
- **Structural variant** — A large-scale alteration in the genome, such as a deletion, duplication, inversion, or translocation.
- **Multi-nucleotide variant (MNV)** — A variation that affects multiple consecutive nucleotides in the genome.
- **Mosaic variant** — A genetic variant that is present in some but not all cells of an organism, often arising during development.
- **Somatic variant** — A genetic variant that occurs in non-germline cells and is not inherited, often associated with cancer.
- **Germline variant** — A genetic variant that is present in the egg or sperm and can be passed on to offspring.
- **De novo variant** — A genetic variant that arises spontaneously in an individual and is not inherited from either parent.

### Difficult Regions

- **Segmental duplication** — Large, highly similar sequences in the genome that can complicate read alignment and variant calling.
- **Paralog / Paralogous gene** — A gene that is related to another gene in the same organism due to a duplication event.
- **Homopolymer** — A sequence of identical nucleotides in a row, which can be prone to sequencing errors.
- **Low-complexity region** — A region of the genome with a simple sequence composition, which can be challenging for alignment and variant calling.
- **HLA region / MHC** — The human leukocyte antigen (HLA) region, also known as the major histocompatibility complex (MHC), is a highly polymorphic region involved in immune response.

### Benchmarking

- **Precision (positive predictive value)** — The proportion of true positive variant calls among all positive calls.
- **Recall (sensitivity)** — The proportion of true positive variant calls detected among all actual variants.
- **F1 score** — The harmonic mean of precision and recall, providing a single metric for evaluating variant calling performance.
- **True positive (TP) / False positive (FP) / False negative (FN)** — Metrics used to evaluate the accuracy of variant calls, where TP represents correctly identified variants, FP represents incorrectly identified variants, and FN represents missed variants.
- **High-confidence region** — A region of the genome where variant calls are considered to be highly reliable, often used for benchmarking and validation.

### Key Resources/Tools (may warrant brief glossary entries)

- **GIAB (Genome in a Bottle)** — A consortium that develops reference materials and data for benchmarking genome sequencing and variant calling.
- **DeepVariant** — A deep learning-based variant caller developed by Google that identifies genetic variants from sequencing data.
- **GLnexus** — A tool for joint variant calling across multiple samples, designed to work with DeepVariant outputs.
- **HaplotypeCaller** — A variant caller from the Genome Analysis Toolkit (GATK) that uses local de-novo assembly of haplotypes to call variants.

## CH 02 

### Reference & Coordinate Systems

- **Reference genome/assembly** — A digital nucleic acid sequence database, assembled as a representative example of a species' set of genes. Multiple versions exist.
- **GRCh37** — The 37th version of the Genome Reference Consortium human genome assembly.
- **GRCh38** — The 38th version of the Genome Reference Consortium human genome assembly.
- **T2T-CHM13** — The Telomere-to-Telomere (T2T) CHM13 human genome assembly, representing a complete, gapless sequence of a human genome.
- **Pangenome reference** — A reference that represents the genetic diversity of a species, rather than a single individual.
- **Gene model** — A representation of the structure of a gene, including its exons, introns, and regulatory elements.
- **Canonical transcript** — The most biologically relevant transcript of a gene, often used as the reference for annotation.
- **Alternative transcript/isoform** — Different versions of a transcript produced from the same gene due to alternative splicing or other mechanisms.
- **MANE Select** — Matched Annotation from NCBI and EMBL-EBI (MANE) Select is a set of transcripts that are consistently annotated across databases.

### Variant Types & Properties

- **Allele frequency** — The proportion of a specific allele among all alleles of a gene in a population.
- **MAF (minor allele frequency)** — The frequency at which the less common allele occurs in a given population.
- **rsID** — A unique identifier assigned to a single nucleotide polymorphism (SNP) in the dbSNP database.
- **Loss-of-function (LoF) variant** — A genetic variant that results in reduced or abolished protein function.
- **Ultra-rare variant** — A genetic variant that is extremely uncommon in the population, often with a frequency of less than 0.01%.

### Population Genetics Metrics

- **Linkage disequilibrium** — A non-random association of alleles at different loci in a given population.
- **pLI (probability of being loss-of-function intolerant)** — A metric that estimates the likelihood that a gene is intolerant to loss-of-function variants.
- **LOEUF (loss-of-function observed/expected upper bound fraction)** — A metric that quantifies the observed versus expected number of loss-of-function variants in a gene.
- **Constraint metrics** — Metrics that assess the tolerance of a gene to functional genetic variation.
- **Imputation** — The process of inferring unobserved genotypes in a study sample based on observed genotypes and a reference panel.

### Functional Genomics

- **ChIP-seq** — Chromatin Immunoprecipitation followed by sequencing, a method used to analyze protein-DNA interactions.
- **DNase-seq** — A method to identify regions of open chromatin by sequencing DNA fragments generated by DNase I digestion.
- **ATAC-seq** — Assay for Transposase-Accessible Chromatin using sequencing, a technique to study chromatin accessibility.
- **Hi-C** — A method to study the three-dimensional architecture of genomes by capturing chromatin interactions.
- **Chromatin accessibility** — The degree to which DNA is exposed and available for binding by proteins, often assessed by DNase-seq or ATAC-seq.
- **Histone modification** — Chemical modifications to histone proteins that can influence chromatin structure and gene expression.
- **Peak calling** — The process of identifying regions of the genome with significant enrichment of sequencing reads, often used in ChIP-seq and ATAC-seq analyses.
- **Signal track** — A graphical representation of sequencing data across the genome, showing the intensity of signals such as read coverage or enrichment.

### Expression Genetics

- **eQTL (expression quantitative trait locus)** — A genomic locus that explains variation in gene expression levels.
- **Splicing QTL** — A genomic locus that affects the splicing of pre-mRNA.
- **Molecular QTL** — A quantitative trait locus that influences molecular traits such as gene expression, protein levels, or metabolite concentrations.
- **Cis-regulatory** — Referring to regulatory elements, such as promoters or enhancers, that are located on the same molecule of DNA as the gene they regulate.
- **Colocalization** — The occurrence of two or more genetic signals at the same genomic location, suggesting a shared causal variant.
- **Dropout (single-cell context)** — The failure to detect a transcript in a single-cell RNA-seq experiment, often due to low mRNA capture efficiency.

### Clinical Interpretation

- **ACMG/AMP criteria** — A set of guidelines developed by the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) for the interpretation of sequence variants. These criteria provide a framework for classifying variants into categories such as pathogenic, likely pathogenic, uncertain significance, likely benign, and benign based on various lines of evidence.
- **Pathogenicity** — The ability of a genetic variant to cause disease.
- **Haploinsufficiency** — A condition in which a single functional copy of a gene is insufficient to maintain normal function, leading to a disease phenotype.
- **Triplosensitivity** — A condition in which an extra copy of a gene leads to a disease phenotype.
- **Gene-disease validity** — The strength of evidence supporting a relationship between a gene and a disease.
- **Pharmacogenomics** — The study of how genetic variation affects an individual's response to drugs.
- **Diplotype** — The combination of alleles at multiple loci on a single chromosome that are inherited together.

### Study Designs & Statistics

- **GWAS summary statistics** — Aggregated data from genome-wide association studies, typically including information on the association between genetic variants and traits across the genome.
- **Fine-mapping** — The process of identifying the specific causal variants within a genomic region associated with a trait.
- **Effect size** — A measure of the strength of the relationship between a genetic variant and a trait.
- **Ascertainment bias** — A systematic distortion in the estimation of genetic effects due to non-random sampling of individuals or variants.

## CH 03
## CH 04
## CH 05
## CH 06
## CH 07
## CH 08
## CH 09
## CH 10
## CH 11
## CH 12
## CH 13
## CH 14
## CH 15
## CH 16
## CH 17
## CH 18
## CH 19
## CH 20
## APX A
## APX B
